Revance Therapeutics, Inc. (RVNC)

NASDAQ: RVNC · IEX Real-Time Price · USD
12.13
-0.23 (-1.86%)
Jan 28, 2022 2:27 PM EST - Market open
Market Cap870.87M
Revenue (ttm)62.98M
Net Income (ttm)-296.52M
Shares Out71.79M
EPS (ttm)-4.47
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume563,434
Open12.34
Previous Close12.36
Day's Range11.84 - 12.48
52-Week Range11.84 - 33.83
Beta0.87
AnalystsBuy
Price Target28.11 (+131.7%)
Earnings DateFeb 21, 2022

About RVNC

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe late...

IndustryPharmaceuticals
IPO DateFeb 6, 2014
CEOMark Foley
Employees470
Stock ExchangeNASDAQ
Ticker SymbolRVNC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for RVNC stock is "Buy." The 12-month stock price forecast is 28.11, which is an increase of 131.74% from the latest price.

Price Target
$28.11
(131.74% upside)
Analyst Consensus: Buy

News

RVNC SHAREHOLDER ALERT: Jakubowitz Law Reminds Revance Shareholders of a Lead Plaintiff Deadline of February 8, 2022

NEW YORK, Jan. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). To rec...

24 minutes ago - PRNewsWire

Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud C...

Radnor, Pennsylvania--(Newsfile Corp. - January 28, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed agai...

2 hours ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, I...

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) and certain of i...

18 hours ago - PRNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revance Therapeutics, Inc. of a Class Action Lawsui...

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Revance Therapeuti...

1 day ago - PRNewsWire

RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit

LOS ANGELES, Jan. 27, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...

1 day ago - PRNewsWire

Revance Therapeutics Shareholder Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York--...

1 day ago - Newsfile Corp

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Revance Therapeutics, Inc. of a Class Action Lawsuit a...

NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The Gross Law Firm, securities class action litigators, issues the following notice to shareholders of Revance Therapeutics, Inc.: Shareholders who purchased shar...

1 day ago - PRNewsWire

Shareholder Action Alert: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,...

Los Angeles, California--(Newsfile Corp. - January 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...

2 days ago - Newsfile Corp

ROSEN, A LEADING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Coun...

NEW YORK, Jan. 25, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 201...

2 days ago - PRNewsWire

Investor Action Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,...

Los Angeles, California--(Newsfile Corp. - January 25, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...

3 days ago - Newsfile Corp

Shareholder Action Notice: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100...

Los Angeles, California--(Newsfile Corp. - January 24, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...

4 days ago - Newsfile Corp

RVNC ALERT: Thornton Law Firm Reminds Revance Therapeutics Investors of Securities Class Action

Boston, Massachusetts--(Newsfile Corp. - January 24, 2022) - The Thornton Law Firm reminds investors that a class action lawsuit has been filed on behalf of investors of Revance Therapeutics, Inc. (NASD...

4 days ago - Newsfile Corp

UPCOMING DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action...

San Diego, California--(Newsfile Corp. - January 24, 2022) -  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Revance Therapeutics, Inc. (NASDAQ: RVNC) securities between Nove...

4 days ago - Newsfile Corp

Revance Therapeutics Inc. News: Berger Montague Investigates Securities Fraud Allegations Against Revance Therapeutic...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 24, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities of Revance Therapeutic...

4 days ago - Newsfile Corp

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Agai...

Radnor, Pennsylvania--(Newsfile Corp. - January 23, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed agai...

5 days ago - Newsfile Corp

Revance Therapeutics Class Action Reminder

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York--...

5 days ago - Newsfile Corp

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf...

NEW YORK--(BUSINESS WIRE)---- $RVNC--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California o...

6 days ago - Business Wire

Thornton Law Firm Reminds Revance Therapeutics (RVNC) Investors of Securities Class Action

Boston, Massachusetts--(Newsfile Corp. - January 21, 2022) - The Thornton Law Firm reminds investors that a class action lawsuit has been filed on behalf of investors of Revance Therapeutics, Inc. (NASD...

1 week ago - Newsfile Corp

RVNC LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Revance Therapeuti...

New York, New York--(Newsfile Corp. - January 21, 2022) -  The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Revance Therapeu...

1 week ago - Newsfile Corp

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit an...

NEW YORK, Jan. 20, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Revance Therapeuti...

1 week ago - PRNewsWire

SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds RVNC Investors of Securities Fraud Class Action Lawsuit...

RADNOR, Pa., Jan. 20, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Revance Therapeutics, Inc. (...

1 week ago - PRNewsWire

RVNC CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces to Revance Therapeutics, Inc. Investors of Dead...

Radnor, Pennsylvania--(Newsfile Corp. - January 18, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Revance The...

1 week ago - Newsfile Corp

Lost Money in Revance Therapeutics, Inc.?

OAKLAND, Calif.--(BUSINESS WIRE)---- $RVNC #RVNC--Gibbs Law Group continues to investigate potential legal claims on behalf of Revance investors.

1 week ago - Business Wire

Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Me...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA

1 week ago - Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics,...

LOS ANGELES, Jan. 18, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Re...

1 week ago - PRNewsWire